Schedule 13G ownership disclosure

SKYSTAR BIO-PHARMACEUTICAL CO

Security class unavailable · CUSIP: 830884102

Event date: 2014-07-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
858,435
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-14-000065
Form type
SC 13G
Filer
SABBY MANAGEMENT, LLC
CIK
CIK 1535610
Filed
Jul 17, 2014
Reporting period
Jul 16, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub